Medication Data Science, Inc. (MeDS)

Cover Block

Attribute	Value
Company Name	Medication Data Science, Inc. (MeDS)
Tagline	Builds AI and data pipelines to secure medication workflows, reduce dispensing errors, and improve clinical outcomes. [meds-ai.com, retrieved 2026]
Headquarters	Ann Arbor, Michigan, United States
Founded	2025
Stage	Pre-Seed
Business Model	B2B
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding Label	Angel-Backed
Total Disclosed	~$50,000 [Medication Data Science 2026 Company Profile, retrieved 2026]

Links

• Website: https://www.meds-ai.com/

Executive Summary

Medication Data Science, Inc. (MeDS) is an academic spinout applying AI to the medication use lifecycle, a high-stakes but fragmented area of healthcare where data-driven errors have significant clinical and financial consequences [meds-ai.com, retrieved 2026]. Founded in 2025 by University of Michigan researchers, the company aims to build data pipelines that impact electronic prescribing, dispensing, insurance auditing, and medication therapy management [meds-ai.com, retrieved 2026]. The core product focuses on AI-powered verification to catch mismatches during e-prescribing and analytics to monitor dispensing patterns, integrating directly into pharmacist workflows [meds-ai.com, retrieved 2026].

Founding co-lead Dr. Corey Lester leads the eponymous Medication Data Science lab at the university, which provides a direct research conduit into the problems the company is tackling [Medication Data Science (MeDS) Lab | UM College of Pharmacy, retrieved 2026]. The venture is in its earliest stages, having secured a small angel investment from the University of Michigan's Accelerate Blue Fund [PitchBook, 2026]. Over the next 12-18 months, the key watchpoints will be the translation of academic research into a commercially viable product, the securing of initial named pharmacy or health system customers, and the ability to attract institutional capital.

Data Accuracy: YELLOW -- Core product and founding details are confirmed via the company website and university sources; funding and traction metrics are based on limited, unverified disclosures.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	B2B
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding	Angel-Backed

How the Company Got Here

Medication Data Science, Inc. (MeDS) is a 2025 academic spinout from the University of Michigan, commercializing research from the Medication Data Science lab within the College of Pharmacy [Medication Data Science, Inc. (MeDS) | AI for Medication Use, retrieved 2026]. The company is headquartered in Ann Arbor, Michigan, and its founding team consists of University of Michigan researchers, including Dr. Corey Lester and Michael D. Dorsch [Medication Data Science, Inc. (MeDS) | AI for Medication Use, retrieved 2026] [Medication Data Science - UM - Innovation Partnerships, retrieved 2026].

It was incorporated in 2025 and received a $50,000 investment from the Accelerate Blue Fund, an evergreen, early-stage venture fund associated with the University of Michigan [Medication Data Science 2026 Company Profile, retrieved 2026] [Instagram, retrieved 2026].

Data Accuracy: YELLOW -- Company formation and academic origin confirmed by the company website and university partnership page. The $50,000 funding amount is cited by a single database [PitchBook, 2026]; the Accelerate Blue Fund's involvement is confirmed via its own promotional channel [Instagram].

Product and Technology

Medication Data Science (MeDS) builds data pipelines intended to touch multiple stages of the medication lifecycle, including electronic prescribing, medication dispensing, insurance auditing, and medication therapy management [meds-ai.com, retrieved 2026].

Specific product capabilities focus on verification and monitoring. The platform offers AI-powered verification of medication data entry during electronic prescribing to catch mismatches, and provides real-time cross-referencing of drug codes (NDC and RxNorm) with automated alerts for clinically significant discrepancies [meds-ai.com, retrieved 2026]. It integrates into pharmacist workflows and includes safeguards for Schedule II controlled substances. Beyond verification, MeDS is developing data pipelines to monitor dispensing patterns, identify workflow inefficiencies, and surface performance analytics [meds-ai.com, retrieved 2026].

Data Accuracy: YELLOW -- Product claims are sourced directly from the company website; technical implementation and commercial readiness are unverified.

Where the Demand Sits

Medication error prevention and pharmacy workflow optimization are substantiated by third-party research. The Institute of Medicine's report, To Err Is Human, estimated that medication errors harm at least 1.5 million people annually in the United States, with costs exceeding $3.5 billion [Institute of Medicine, 2000]. The U.S. Food and Drug Administration indicates that these errors cause at least one death every day and injure approximately 1.3 million people annually [FDA, 2024].

Market Segment	Value
Pharmacy Automation Systems	$7.2 billion globally, 2024 (Grand View Research)
Clinical Decision Support Systems	$1.6 billion in the U.S., 2023 (Signify Research)
Medication Therapy Management	$4.5 billion globally, 2025 (Transparency Market Research)

Data Accuracy: YELLOW -- Market sizing figures are from third-party analyst reports for analogous sectors; the specific addressable market for MeDS's AI pipelines is not publicly defined.

Competitive Landscape

Medication Data Science (MeDS) is positioned as a specialized data infrastructure layer for pharmacies.

Company	Positioning	Stage / Funding
Medication Data Science (MeDS)	AI data pipelines for medication workflow safety and analytics.	Pre-Seed / Angel-backed.
Amazon Pharmacy	Online pharmacy with integrated AI for customer experience and backend operations.	Public.
Plenful	AI workflow automation for pharmacy operations.	Series A.
Evio	Data science and machine learning platform for healthcare product development.	Venture-backed.

Data Accuracy: YELLOW -- Competitor positioning and funding stages are drawn from public sources, but direct feature comparisons are inferred from company descriptions.

Opportunity

MeDS aims to become the default data infrastructure layer for medication safety across community and hospital pharmacy networks. The company's focus on building AI and data pipelines across the full medication use lifecycle positions it to address medication errors [meds-ai.com, retrieved 2026].

Scenario	Catalyst
Standardization by a Major PBM	A pilot partnership with a regional chain demonstrating a quantifiable reduction in dispensing errors.
Embedded Infrastructure for EHRs	Publication of peer-reviewed research from the founding team's lab validating the AI model's performance.
Data Consortium Formation	Securing a critical mass of pharmacy partners and demonstrating unique insights.

Data Accuracy: YELLOW -- The core product vision and academic origin are confirmed by the company website and university sources. The growth scenarios are analytical extrapolations.

Sources

1. [meds-ai.com, retrieved 2026] Medication Data Science, Inc. (MeDS) | AI for Medication Use | https://www.meds-ai.com/
2. [Medication Data Science (MeDS) Lab | UM College of Pharmacy, retrieved 2026] Medication Data Science (MeDS) Lab | UM College of Pharmacy | https://pharmacy.umich.edu/lab/medication-data-science-lab/
3. [Medication Data Science - UM - Innovation Partnerships, retrieved 2026] Medication Data Science - UM - Innovation Partnerships | https://innovationpartnerships.umich.edu/company/medication-data-science/
4. [Medication Data Science 2026 Company Profile, retrieved 2026] Medication Data Science 2026 Company Profile | https://pitchbook.com/profiles/company/1164970-00
5. [Instagram, retrieved 2026] The Accelerate Blue Fund is an evergreen, early-stage... | https://www.instagram.com/p/DPErOock-K3/
6. [Institute of Medicine, 2000] To Err Is Human: Building a Safer Health System | https://pubmed.ncbi.nlm.nih.gov/25077248/
7. [FDA, 2024] Working to Reduce Medication Errors | https://www.fda.gov/drugs/information-consumers-and-patients-drugs/working-reduce-medication-errors
8. [Futurum Group] Gen AI Case Study: Amazon Pharmacy | The AI Moment | https://futurumgroup.com/insights/gen-ai-case-study-amazon-pharmacy-the-ai-moment-episode-13/
9. [plenful.com, retrieved 2026] Customer and Success Stories | https://www.plenful.com/customers
10. [greenhouse.io, retrieved 2026] Job Application for Data Science and Machine Learning Product Manager (Remote) at Evio | http://job-boards.greenhouse.io/evio/jobs/4693266005
11. [Corey Lester - UM College of Pharmacy - University of Michigan, retrieved 2026] Corey Lester - UM College of Pharmacy - University of Michigan | https://pharmacy.umich.edu/people/lester-corey/